Mestranol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 3-Methoxy-19-nor-17α-pregna-1,3,5(10)-trien-20-yn-17-ol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a601050 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 72-33-3 |
| ATC code | None |
| PubChem | CID 6291 |
| DrugBank | DB01357 |
| ChemSpider | 6054 |
| UNII | B2V233XGE7 |
| KEGG | D00575 |
| ChEBI | CHEBI:6784 |
| ChEMBL | CHEMBL1201151 |
| Synonyms | (8S,9S,13S,14S,17S)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol |
| Chemical data | |
| Formula | C21H26O2 |
| Mol. mass | 310.43 g/mol |
|
|
|
|
| |
|
Mestranol is the 3-methyl ether of ethinylestradiol. It was the estrogen used in many of the first oral contraceptives.
It is a biologically inactive prodrug of ethinylestradiol to which it is demethylated in the liver with a conversion efficiency of 70% (50 µg of mestranol is pharmacokinetically bioequivalent to 35 µg of ethinylestradiol).[1]
References [edit]
- ^ Faigle, Johann W.; Schenkel, Lotte (1998). "Pharmacokinetics of estrogens and progestogens". In in Fraser, Ian S. (ed.). Estrogens and Progestogens in Clinical Practice. London: Churchill Livingstone. pp. 273–294. ISBN 0-443-04706-5.
| This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |